Search Press releases Keywords From To 8 Jul 2025 UCB presents latest research advancements at European Pediatric Neurology Society Congress Read More 27 Jun 2025 UCB announces positive results from GEMZ phase 3 study of fenfluramine in CDKL5 Deficiency Disorder Read More 20 Jun 2025 UCB to present new data from its neurology portfolio at the 11th European Academy of Neurology (EAN) Congress 2025 Read More 16 Jun 2025 Transparency notification FMR LLC Read More 12 Jun 2025 UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity Read More 12 Jun 2025 Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity Read More Pagination First page Previous page Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Page 2 of 69 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
